BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25175498)

  • 1. Targeting forkhead box transcription factors FOXM1 and FOXO in leukemia (Review).
    Zhu H
    Oncol Rep; 2014 Oct; 32(4):1327-34. PubMed ID: 25175498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXO transcription factors in cancer development and therapy.
    Coomans de Brachène A; Demoulin JB
    Cell Mol Life Sci; 2016 Mar; 73(6):1159-72. PubMed ID: 26686861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.
    Paik JH; Kollipara R; Chu G; Ji H; Xiao Y; Ding Z; Miao L; Tothova Z; Horner JW; Carrasco DR; Jiang S; Gilliland DG; Chin L; Wong WH; Castrillon DH; DePinho RA
    Cell; 2007 Jan; 128(2):309-23. PubMed ID: 17254969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXOs support the metabolic requirements of normal and tumor cells by promoting IDH1 expression.
    Charitou P; Rodriguez-Colman M; Gerrits J; van Triest M; Groot Koerkamp M; Hornsveld M; Holstege F; Verhoeven-Duif NM; Burgering BM
    EMBO Rep; 2015 Apr; 16(4):456-66. PubMed ID: 25648147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics.
    Tabnak P; Hasanzade Bashkandi A; Ebrahimnezhad M; Soleimani M
    Cancer Cell Int; 2023 Oct; 23(1):238. PubMed ID: 37821870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forkhead box transcription factors in embryonic heart development and congenital heart disease.
    Zhu H
    Life Sci; 2016 Jan; 144():194-201. PubMed ID: 26656470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXO genes act in vivo as tumor suppressors.
    Cancer Biol Ther; 2007 Feb; 6(2):132-3. PubMed ID: 17585407
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line.
    Tüfekçi Ö; Yandım MK; Ören H; İrken G; Baran Y
    Leuk Res; 2015 Mar; 39(3):342-7. PubMed ID: 25557384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance.
    Zhao F; Lam EW
    Front Med; 2012 Dec; 6(4):376-80. PubMed ID: 23124885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas.
    Maekawa A; Kohashi K; Kuda M; Iura K; Ishii T; Endo M; Nakatsura T; Iwamoto Y; Oda Y
    BMC Cancer; 2016 Jul; 16():511. PubMed ID: 27439614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metformin on FOXM1 expression and on the biological behavior of acute leukemia cell lines.
    Zhang B; Liu LL; Mao X; Zhang DH
    Mol Med Rep; 2014 Dec; 10(6):3193-8. PubMed ID: 25310131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
    Wierstra I
    Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance.
    Gomes AR; Zhao F; Lam EW
    Chin J Cancer; 2013 Jul; 32(7):365-70. PubMed ID: 23706767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Forkhead Box Class O proteins in cancer progression and metastasis.
    Kim CG; Lee H; Gupta N; Ramachandran S; Kaushik I; Srivastava S; Kim SH; Srivastava SK
    Semin Cancer Biol; 2018 Jun; 50():142-151. PubMed ID: 28774834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
    Teh MT; Wong ST; Neill GW; Ghali LR; Philpott MP; Quinn AG
    Cancer Res; 2002 Aug; 62(16):4773-80. PubMed ID: 12183437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
    Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FoxO1 and FoxM1 transcription factors have antagonistic functions in neonatal cardiomyocyte cell-cycle withdrawal and IGF1 gene regulation.
    Sengupta A; Kalinichenko VV; Yutzey KE
    Circ Res; 2013 Jan; 112(2):267-77. PubMed ID: 23152492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer.
    Yoshida Y; Wang IC; Yoder HM; Davidson NO; Costa RH
    Gastroenterology; 2007 Apr; 132(4):1420-31. PubMed ID: 17408638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting FOXM1 in cancer.
    Halasi M; Gartel AL
    Biochem Pharmacol; 2013 Mar; 85(5):644-652. PubMed ID: 23103567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation.
    Polter A; Yang S; Zmijewska AA; van Groen T; Paik JH; Depinho RA; Peng SL; Jope RS; Li X
    Biol Psychiatry; 2009 Jan; 65(2):150-9. PubMed ID: 18823877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.